176 related articles for article (PubMed ID: 36009795)
1. Elevated Serum Levels of IgG4 in Patients with Heart Failure with Reduced Ejection Fraction: A Prospective Controlled Study.
Volodarsky I; Anton A; Zilberman L; Fugenfirov I; Neumark E; Malnick S; Levy Y; George J; Goland S
Biology (Basel); 2022 Aug; 11(8):. PubMed ID: 36009795
[TBL] [Abstract][Full Text] [Related]
2. Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction.
Vicent L; Álvarez-García J; Vazquez-Garcia R; González-Juanatey JR; Rivera M; Segovia J; Pascual-Figal D; Bover R; Worner F; Fernández-Avilés F; Ariza-Sole A; Martínez-Sellés M
J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109365
[TBL] [Abstract][Full Text] [Related]
3. Improvement of peripheral endothelial dysfunction by acute vitamin C application: different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathy.
Erbs S; Gielen S; Linke A; Möbius-Winkler S; Adams V; Baither Y; Schuler G; Hambrecht R
Am Heart J; 2003 Aug; 146(2):280-5. PubMed ID: 12891196
[TBL] [Abstract][Full Text] [Related]
4. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology.
Skwarek M; Bilińska ZT; Mazurkiewicz Ł; Grzybowski J; Kruk M; Kurjata P; Piotrowski W; Ruzyłło W
Kardiol Pol; 2008 May; 66(5):515-22, discussion 523-4. PubMed ID: 18537059
[TBL] [Abstract][Full Text] [Related]
5. Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy.
D'Andrea A; Salerno G; Scarafile R; Riegler L; Gravino R; Castaldo F; Cocchia R; Limongelli G; Romano M; Calabrò P; Nigro G; Cuomo S; Bossone E; Caso P; Calabrò R
Pacing Clin Electrophysiol; 2009 Aug; 32(8):1017-29. PubMed ID: 19659622
[TBL] [Abstract][Full Text] [Related]
6. The circulating level of interleukins 6 and 18 in ischemic and idiopathic dilated cardiomyopathy.
Iravani Saadi M; Babaee Beigi MA; Ghavipishe M; Tahamtan M; Geramizadeh B; Zare A; Yaghoobi R
J Cardiovasc Thorac Res; 2019; 11(2):132-137. PubMed ID: 31384408
[No Abstract] [Full Text] [Related]
7. Pleomorphic Ventricular Tachycardia in Dilated Cardiomyopathy Predicts Ventricular Tachycardia Recurrence After Ablation Independent From Cardiac Function: Comparison With Patients With Ischemic Heart Disease.
Kimura Y; de Riva M; Ebert M; Glashan C; Wijnmaalen AP; Piers SR; Dekkers OM; Trines SA; Zeppenfeld K
Circ Arrhythm Electrophysiol; 2023 Jan; 16(1):e010826. PubMed ID: 36595629
[TBL] [Abstract][Full Text] [Related]
8. Reduced right ventricular ejection fraction as a marker for idiopathic dilated cardiomyopathy compared with ischemic left ventricular dysfunction.
La Vecchia L; Zanolla L; Varotto L; Bonanno C; Spadaro GL; Ometto R; Fontanelli A
Am Heart J; 2001 Jul; 142(1):181-9. PubMed ID: 11431676
[TBL] [Abstract][Full Text] [Related]
9. Association between left atrial myocardial function and exercise capacity in patients with either idiopathic or ischemic dilated cardiomyopathy: a two-dimensional speckle strain study.
D'Andrea A; Caso P; Romano S; Scarafile R; Cuomo S; Salerno G; Riegler L; Limongelli G; Di Salvo G; Romano M; Liccardo B; Iengo R; Ascione L; Del Viscovo L; Calabrò P; Calabrò R
Int J Cardiol; 2009 Mar; 132(3):354-63. PubMed ID: 18255178
[TBL] [Abstract][Full Text] [Related]
10. Assessments of left ventricular function during exercise in patients with dilated cardiomyopathy: comparison with ischemic cardiomyopathy.
Konishi T; Koyama T; Aoki T; Yada T; Futagami Y; Sekioka K; Nakano T
J Cardiol; 1989 Sep; 19(3):797-804. PubMed ID: 2641774
[TBL] [Abstract][Full Text] [Related]
11. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
Rochette L; Tatou E; Vergely C; Maupoil V; Bouchot O; Mossiat C; Jazayeri S; Benkhadra S; Brenot R; Girard C; David M
J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
[TBL] [Abstract][Full Text] [Related]
12. Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.
Streitner F; Kuschyk J; Dietrich C; Mahl E; Streitner I; Doesch C; Veltmann C; Schimpf R; Wolpert C; Borggrefe M
Clin Cardiol; 2011 Oct; 34(10):604-9. PubMed ID: 21887690
[TBL] [Abstract][Full Text] [Related]
13. Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy.
Mathier MA; Rose GA; Fifer MA; Miyamoto MI; Dinsmore RE; Castaño HH; Dec GW; Palacios IF; Semigran MJ
J Am Coll Cardiol; 1998 Jul; 32(1):216-24. PubMed ID: 9669273
[TBL] [Abstract][Full Text] [Related]
14. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy.
McLeod CJ; Shen WK; Rea RF; Friedman PA; Hayes DL; Wokhlu A; Webster TL; Wiste HJ; Hodge DO; Bradley DJ; Hammill SC; Packer DL; Cha YM
Heart Rhythm; 2011 Mar; 8(3):377-82. PubMed ID: 21070886
[TBL] [Abstract][Full Text] [Related]
15. Ghrelin Derangements in Idiopathic Dilated Cardiomyopathy: Impact of Myocardial Disease Duration and Left Ventricular Ejection Fraction.
Aleksova A; Beltrami AP; Bevilacqua E; Padoan L; Santon D; Biondi F; Barbati G; Stenner E; Gortan Cappellari G; Barazzoni R; Ziberna F; Zwas DR; Avraham Y; Agostoni P; Not T; Livi U; Sinagra G
J Clin Med; 2019 Aug; 8(8):. PubMed ID: 31375017
[TBL] [Abstract][Full Text] [Related]
16. [T1 mapping and late gadolinium enhancement for the diagnosis of dilated cardiomyopathy].
Cui Q; Yu J; Ge X; Gao G; Liu Y; Shen W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1506-1510. PubMed ID: 33541506
[TBL] [Abstract][Full Text] [Related]
17. Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy Patients.
Raafs AG; Boscutti A; Henkens MTHM; van den Broek WWA; Verdonschot JAJ; Weerts J; Stolfo D; Nuzzi V; Manca P; Hazebroek MR; Knackstedt C; Merlo M; Heymans SRB; Sinagra G
J Am Heart Assoc; 2022 Mar; 11(6):e024505. PubMed ID: 35253464
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy.
Tompkins BA; Rieger AC; Florea V; Banerjee MN; Natsumeda M; Nigh ED; Landin AM; Rodriguez GM; Hatzistergos KE; Schulman IH; Hare JM
J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30005555
[TBL] [Abstract][Full Text] [Related]
19. Global plasma protein profiling reveals DCM characteristic protein signatures.
Feig MA; Pop C; Bhardwaj G; Sappa PK; Dörr M; Ameling S; Weitmann K; Nauck M; Lehnert K; Beug D; Kühl U; Schultheiss HP; Völker U; Felix SB; Hammer E
J Proteomics; 2019 Oct; 209():103508. PubMed ID: 31476444
[TBL] [Abstract][Full Text] [Related]
20. Circulating chemerin levels elevated in dilated cardiomyopathy patients with overt heart failure.
Zhang O; Ji Q; Lin Y; Wang Z; Huang Y; Lu W; Liu X; Zhang J; Liu Y; Zhou YJ
Clin Chim Acta; 2015 Aug; 448():27-32. PubMed ID: 26057200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
